Phase 2a trial of DFV890 and MAS825 for inflammation in CHD/CHIP patients completes with 31 participants
Can two experimental drugs calm the dangerous inflammation linked to heart disease and a blood condition called CHIP?
A Phase 2a, multi-center, randomized, placebo-controlled, blinded study evaluated the efficacy, safety, and tolerability of DFV890 (oral dai…
A new trial tested two experimental drugs to safely turn down the dangerous inflammation driving heart disease in patients with CHIP.
GBM model predicts postoperative delirium in elderly CHD patients with 0.856 AUC
Can a computer model predict post-surgery confusion in older heart patients? A new tool shows promise.
A retrospective cohort study of 861 elderly patients with coronary heart disease (CHD) undergoing non-cardiac surgery developed a gradient b…
A new computer tool predicts post-surgery confusion in older heart patients by analyzing frailty, memory, and sleep patterns to help doctors…
Web Portal Use in Type 2 Diabetes: Uptake Driven by Intentions, Not Frequency
Why Do Some Patients with Diabetes Use Health Apps More Than Others?
In a secondary analysis of an RCT, higher education, openness, and intentions regarding physical activity and nutrition significantly increa…
Higher education and a strong desire to eat healthy drove diabetes patients to use health apps, while just wanting to improve health wasn't …